Vibrotactile Stimulation for Upper-Extremity Stroke Rehabilitation
Vibrotactile Stimulation for Neurological Disorders
1 other identifier
interventional
24
1 country
2
Brief Summary
The goal of this clinical trial is to investigate upper-extremity vibrotactile stimulation with wearables in stroke patients. The main questions it aims to answer are: Are the wearables well-tolerated by patients? Does the vibrotactile stimulation help regain arm function? Participants will wear vibrotactile stimulation gloves and shirts for 5 hours daily during their stay at the rehabilitation unit, in addition to conventional therapy. Researchers will compare the treatment group (vibrotactile stimulation wearables) with a control group (conventional therapy only) to see the effects of the vibrotactile stimulation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_1 stroke
Started Feb 2024
Shorter than P25 for phase_1 stroke
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 29, 2024
CompletedStudy Start
First participant enrolled
February 2, 2024
CompletedFirst Posted
Study publicly available on registry
February 6, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 2, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 2, 2025
CompletedApril 11, 2024
April 1, 2024
1 year
January 29, 2024
April 9, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Fugl-Meyer Test of Sensorimotor Function After Stroke (UEFM)
An impairment based measure consisting of 33 movements that tests motor and sensation of the affected arm. Higher scores indicate less impairment and more isolated motions. Scores are between 0 and 66.
Baseline, End of the study (approximately 1-3 weeks, at discharge from the rehabilitation unit).
Secondary Outcomes (4)
Number of participants with at least one adverse event
End of the study (approximately 1-3 weeks, at discharge from the rehabilitation unit).
Number of participants who completed the therapy
End of the study (approximately 1-3 weeks, at discharge from the rehabilitation unit).
Number of participants who tolerated the vibrotactile stimulation therapy
End of the study (approximately 1-3 weeks, at discharge from the rehabilitation unit).
Change in the modified Ashworth scale
Baseline, End of the study (approximately 1-3 weeks, at discharge from the rehabilitation unit).
Study Arms (2)
Vibrotactile Stimulation
EXPERIMENTALParticipants wear vibrotactile stimulation shirts and gloves for 5 hours per day, 7 days per week, during their stay at the rehabilitation unit, which is expected to be between 2-3 weeks. Participants wear the devices after conventional therapy is done for the day.
Control
NO INTERVENTIONParticipants undergo conventional therapy only.
Interventions
Shirts contain embedded vibration motors that stimulate the impaired upper-extremity at 18 different locations. The gloves stimulates the fingertips.
Eligibility Criteria
You may qualify if:
- Inpatients at rehabilitation units
- Unilateral left or right sided ischemic stroke within the previous 2 weeks
- Have Upper-Extremity Fugl-Meyer scores between 6 and 58
- Have at least 20 degrees of active shoulder elevation and elbow flexion
- Expected to stay 1-3 weeks in the rehabilitation unit
You may not qualify if:
- Under anti-spasticity therapy
- Patients that are dependent on pacemakers
- Patients that have defibrillators
- Have lymphedema or AV fistula for dialysis on an arm
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
UCHealth Rehabilitation Unit
Aurora, Colorado, 80045, United States
Broomfield Hospital
Broomfield, Colorado, 80021, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 29, 2024
First Posted
February 6, 2024
Study Start
February 2, 2024
Primary Completion
February 2, 2025
Study Completion
February 2, 2025
Last Updated
April 11, 2024
Record last verified: 2024-04